HengHong Technology Inc.

HengHong Technology Inc. publicly filed a registration statement on Form F-1 on Mar 27, 2025 for a proposed initial public offering on Nasdaq Capital Market, and has not yet priced. Its latest amendment was filed on Sep 2, 2026. The filing shows a price range of $6.00–$7.00 per share. Underwriters named in the filing: Kingswood.

HengHong Technology Inc. distributes pharmaceutical products in China, mainly traditional Chinese medicines and chemical medical products, primarily through Hainan HengCheng Health Industrial Co., Ltd., and also provides promotion and marketing services.

Status

Filed, not priced

Exchange

Nasdaq Capital Market

Price range

$6.00–$7.00

First filed

Mar 27, 2025

Latest amendment

Sep 2, 2026

Underwriters

Kingswood

Sector

Healthcare

Country / state

China